There are several stocks that passed through the screen and (ANGO) is one of them. Here are the key reasons why this stock is a solid choice for "trend" investing. A solid price increase over a ...

AngioDynamics Loses -15.86% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner A downtrend has been apparent in AngioDynamics (NASDAQ: ANGO) lately with too much selling pressure.

So take a moment to sympathize with the long term shareholders of AngioDynamics, Inc. (NASDAQ:ANGO), who have seen the share price tank a massive 77% over a three year period. That would certainly ...

Quest Partners LLC acquired a new stake in AngioDynamics, Inc. (NASDAQ:ANGO – Free Report ... In other AngioDynamics news, CEO James C. Clemmer bought 20,000 shares of the business’s stock ...

GSA Capital Partners LLP grew its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO – Free Report ... 43% of the company’s stock. In related news, CEO James C. Clemmer acquired 20,000 ...

AngioDynamics, Inc. ANGO recently announced that Irreversible Electroporation (IRE) has received Current Procedural Terminology (CPT) Category I codes for the treatment of lesions in the prostate ...